ACE and hydrops fetalis: In compliance with the guidelines for the treatment of HF and ethical requirements, all patients with HF received angiotensin-converting enzyme inhibitor/angiotensin receptor blocker (ACE-I/ARB), beta-blockers or Aldactone (ALD) without drug use contraindications.